オハイオにおける膵臓がんの臨床試験
オハイオ内の拠点で、膵臓がんに関する45件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Taylor Cancer Research Center, Maumee
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Cleveland Clinic - Oncology Department, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- The Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Taylor Cancer Research Center, Maumee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Facilities Design and Construction - Energy Advancement and Innovation Center, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07117032Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- University of Cincinnati Medical Center, Cincinnati
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US050, Cleveland
- Investigative Site US020, Cleveland
- Investigative Site US033, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073A Study Evaluating a New Radiation Treatment Workflow (NGDS)
- University Hospital Cleveland Medical Center, Cleveland
被験者募集中
21歳以上 · 全性別 · 2026/09/17更新 · NCT07824583EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT06263088Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05720338Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
被験者募集中観察研究
17歳以下 · 全性別 · 2026/09/11更新 · NCT06651580Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
- UH Cleveland Medical Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/10更新 · NCT05764720A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- The Ohio State University (OSU) Wexner Medical Center, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573The Vanguard Study: Testing a New Way to Screen for Cancer
- Louis Stokes Cleveland VA Medical Center, Cleveland
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Aultman Health Foundation, Canton
- Miami Valley Hospital South, Centerville
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- 他11件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328Pancreatic Cancer Early Detection Consortium
- The Ohio State University, Columbus
被験者募集中観察研究健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/07/22更新 · NCT04970056Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/06/15更新 · NCT03711890A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- The Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT04890613Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- The Christ Hospital, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Miami Valley Hospital South, Centerville
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- 他10件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Christ Hospital Cancer Center, Cincinnati
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/03/23更新 · NCT05961982Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
- The Ohio State University, Columbus
被験者募集中
19歳以上 · 全性別 · 2026/02/27更新 · NCT04588025A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
- Taylor Cancer Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/27更新 · NCT07049055A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT07124611Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Cleveland Clinic, Cleveland
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Cincinnati
- Ohio State University-Telemedicine, Cleveland
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Cleveland Clinic, Cleveland
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Cleveland Clinic Foundation, Cleveland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/01/16更新 · NCT06973564LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Strecker Cancer Center-Belpre, Belpre
- Marietta Memorial Hospital, Marietta
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Taylor Cancer Research Center (site 204), Maumee
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Cincinnati
- Massive Bio SYNERGY-AI site, Columbus
- Massive Bio SYNERGY-AI site, Mayfield Heights
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774The Cancer of the Pancreas Screening-5 CAPS5)Study
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/09更新 · NCT02000089ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。